Oslo, 10 October 2014
Reference is made to the stock exchange announcement made by Diagenic
ASA ("Diagenic" or the "Company") yesterday, 9 October 2014, regarding
the Minutes from the Extraordinary General Meeting and the resolved
acquisition of New NEL Hydrogen Holding AS (the "Acquisition"), the
private placement of NOK 35 million (the "Private Placement") and the
new share issue of NOK 35 million, with preemptive rights for
shareholders of the Company (the "Rights Issue").
The Company today announces that it has raised NOK 35 million in gross
proceeds through the Private Placement of 53,846,154 new shares, each
with a par value of NOK 0.20, at a price of NOK 0.65 per share.
The net proceeds from the Private Placement will secure growth capital
for the new business area resulting from the acquisition of New NEL
Hydrogen Holding AS ("NEL Hydrogen") and serve as means to settle the
cash consideration in the acquisition.
Notification of allotment and payment instructions for the Private
Placement will be sent to the applicants today through a notification to
be issued by the Manager. The new shares are expected to be delivered to
the subscribers and listed on the Oslo Stock Exchange on or about 17
October 2014, subject to approval of a prospectus. After completion of
the Private Placement, the Company will have 285,082,950 shares
outstanding (including 123,076,923 new shares to be issued in connection
with the Acquisition), each with a par value of NOK 0.20. The Private
Placement was managed by Carnegie AS.
For further information, please contact:
Lars Christian Stugaard
Acting CEO
+47 23 01 49 06 / +47 47 63 05 22
Lars.christian.stugaard@diagenic.com
This information is subject of the disclosure requirements pursuant to
section 5-12 of the Norwegian Securities Trading Act.